Research
at UCSF indicates that clioquinol appears to block the abiogenetic activity of
Huntington's ache in mice and in corpuscle culture.
Evidence
from appearance 2 analytic trials appropriate that clioquinol could arrest
cerebral abatement in Alzheimer's disease, possibly attributable to its
adeptness to act as a chelator for chestnut and zinc ions. This led to
development of analogs including PBT2 as abeyant ameliorative compounds for the
analysis of Alzheimer's disease.
Recent
beastly studies accept credible that clioquinol can about-face the progression
of Alzheimer's, Parkinson's and Huntington's diseases. According to Dr.
Siegfried Hekimi and colleagues at McGill's Department of Biology, clioquinol
acts anon on a protein alleged Clk-1, generally artlessly alleged “clock-1,”
and adeptness apathetic down the crumbling process. They conjecture that this
may explain the credible adeptness of the biologic to be able in the aloft
conditions, but acquaint adjoin individuals experimenting with this drug.
No comments:
Post a Comment